Company: BWAY
Filing Date: 2025-05-01
Form Type: 424B3
Source: 0001171843-25-002668
Chunk: 2

Company: Brainsway Ltd.
Filing Date: 2025-05-01
Form: 424B3
Chunk 2
---
 PROCEEDS                                 |  7 |
| DESCRIPTION OF ORDINARY SHARES                  |  8 |
| DESCRIPTION OF AMERICAN DEPOSITARY SHARES       | 12 |
| SELLING SHAREHOLDER                             | 13 |
| PLAN OF DISTRIBUTION                            | 15 |
| LEGAL MATTERS                                   | 18 |
| EXPERTS                                         | 18 |
| WHERE YOU CAN FIND MORE INFORMATION             | 18 |
| INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE | 19 |
| ENFORCEABILITY OF CIVIL LIABILITIES             | 20 |
| OFFERING EXPENSES                               | 21 |

<div align='center'>ABOUT THIS PROSPECTUS</div>

This prospectus is part of a registration statement
that we filed with the Securities and Exchange Commission, or SEC, utilizing a “shelf” registration process under the Securities
Act of 1933, as amended, or the Securities Act. Under this process, the selling shareholder may offer and sell the securities covered
by this prospectus from time to time, in one or more offerings, in any manner described under the section in this prospectus entitled
“Plan of Distribution.”

Each time the selling shareholder sells securities
under this prospectus, we will, if necessary or required by law or the Registration Rights Agreement, provide a prospectus supplement
to this prospectus that will contain specific information about the terms of that offering. We may also authorize one or more free writing
prospectuses to be provided to you that may contain material information relating to these offerings. Any prospectus supplement may also
add, update or change information contained in or incorporated by reference into this prospectus, and may also contain information about
any material federal income tax considerations relating to the securities covered by the prospectus supplement. If there is any inconsistency
between the information in this prospectus and any applicable prospectus supplement, you should rely on the prospectus supplement. You
should read this prospectus, any applicable prospectus supplement and any free writing prospectus and the documents incorporated by reference
into this prospectus and any applicable prospectus supplement, together with additional information under the headings “Where You
Can Find More Information” and “Incorporation of Certain Documents by Reference.”

You should rely only on the information contained in
or incorporated by reference into this prospectus, any applicable prospectus supplement and any free writing prospectus. Neither we nor
the selling shareholder have authorized anyone to provide you with any information other than that contained